- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05205564
Stress and Coping, Resilience, and Compassion Fatigue of Front-line Nurses During COVID-19 Pandemic
January 25, 2022 updated by: Piao-Yi Chiou, National Taiwan University
The Correlation of Stress and Coping, Resilience, and Compassion Fatigue of Nurses Staying on Front-line During COVID-19 Outbreak in Taiwan
This is a cross-sectional research.
The investigators plan to recruit about 250 front-line nurses who provided direct care to COVID-19 confirmed cases in a medical center in Taiwan.
Online querstionnaires are used to collect the data.
The relationship between variables such as stressors related to COVID-19, coping status, resilience, and compassion fatigue of participants will be analysis to provide the direction of nurses' mental health-related interventions.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
This project aims to identify the prevalence of compassion fatigue and the coping strategies for the nurses who work on the frontline of healthcare and are responsible for caring for patients with COVID-19 in Taiwan.
The investigators planed to carry a cross-sectional study by a reliable and valid online questionnaire to explore the stressors related to COVID-19, coping status, resilience, and compassion fatigue of nurses who had the experience of caring for the COVID-19 confirmed cases in a medical center during the community outbreak in Taiwan from May 2021.
Online questionnaires are used to collect the data.
About two hundred and fifty nurses will be recruited, and the data will be analyzed by descriptive statistics, correlation statistics and Hayes's PROCESS model 6.
It is expected that the research results can understand the current status and relationship of compassion fatigue, resilience and the adaptability of clinical nurses who are caring for the COVID-19 confirmed cases.
The results can be contributed to develop the direction of nurses' mental health-related interventions during pandemic of emerging contagious disease.
Study Type
Observational
Enrollment (Anticipated)
250
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: PIAO-YI CHIOU, doctoral
- Phone Number: 88427 +886-2-23123456
- Email: piaoyi@ntu.edu.tw
Study Contact Backup
- Name: YI-CHEN YEH, Bachelor
- Phone Number: +886937928876
- Email: R08426007@ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- School of Nursing of National Taiwan University
-
Contact:
- PIAO-YI CHIOU, doctoral
- Phone Number: 88427 +886-2-23123456
- Email: piaoyi@ntu.edu.tw
-
-
Zhongzheng Dist.
-
Taipei City, Zhongzheng Dist., Taiwan, 100225
- Recruiting
- National Taiwan University Hospital
-
Contact:
- YI-CHEN YEH
- Phone Number: +886937928876
- Email: R08426007@ntu.edu.tw
-
Taipei City, Zhongzheng Dist., Taiwan, 100
- Recruiting
- National Taiwan University Hospital
-
Contact:
- HSIU-YUN LIU
- Phone Number: +886972651202
- Email: lsyun@ntuh.gov.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Clinical nurses who have been or are still working in hospital, and have directly cared for COVID-19 confirmed cases from May 2021.
Description
Inclusion Criteria:
- Above/include 20-year-old.
- Those who can operate mobile communication software or computers and can fill in online questionnaires.
- Clinical nurses who had provided nursing care for COVID-19 confirmed cases from May 2021.
Exclusion Criteria:
- Those who did not provide nursing care for COVID-19 confirmed cases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interaction effect between research variables
Time Frame: six months to collect and analysis data.
|
Factors including "stressors related to COVID-19", "stress coping", "resilience", and "compassion fatigue" have interaction effect.
|
six months to collect and analysis data.
|
|
Moderation effect between research variables
Time Frame: six months to collect and analysis data.
|
Both "stress coping" and "resilience" moderate the strength relationship between "stressors" and "compassion fatigue".
|
six months to collect and analysis data.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: YI-CHEN YEH, Bachelor, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 25, 2022
Primary Completion (Anticipated)
June 30, 2022
Study Completion (Anticipated)
July 31, 2022
Study Registration Dates
First Submitted
January 21, 2022
First Submitted That Met QC Criteria
January 21, 2022
First Posted (Actual)
January 25, 2022
Study Record Updates
Last Update Posted (Actual)
February 9, 2022
Last Update Submitted That Met QC Criteria
January 25, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Occupational Stress
- Mental Fatigue
- COVID-19
- Fatigue
- Stress, Psychological
- Compassion Fatigue
Other Study ID Numbers
- 202106153RINB
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.